相关实验视频
Updated: Jul 5, 2026

13:07
A Protocol for Transcranial Photobiomodulation Therapy in Mice
Published on: November 18, 2018
12.1K
眼科治疗中的光生物调节:目前的状况和未来的前景
Hasan Chichan1,2, Iftkhar Hamzah Aldujaly1, Konstantinos Michalakis2
1Al-Mustaqbal University, College of Science, Hillah 51001, Babylon, Iraq.
International journal of ophthalmology
|February 19, 2025
概括
光生物调节疗法使用红光治疗视网膜疾病,如黄斑变性和糖尿病黄斑. 这种方法增强了细胞能量,有望改善视力和减少视网膜厚度.
科学领域:
- 眼科医生 眼科 眼科
- 生物医学工程 生物医学工程
- 细胞生物学 细胞生物学
背景情况:
- 光生物调制 (PBM) 使用特定的光波长来产生治疗效果.
- PBM已经显示出治疗各种疾病的潜力,包括心血管,炎症和传染病.
- 眼部疾病是PBM应用的重要兴趣领域.
研究的目的:
- 审查光生物调节在视网膜疾病中的应用.
- 探索眼科红光疗法的机制和临床证据.
- 讨论PBM在治疗复杂视网膜疾病中的未来方向.
主要方法:
- 对眼部疾病的光生物调节现有文献的综述.
- 专注于红光疗法 (630-800nm) 针对线粒体细胞染色体C氧化酶.
- 对临床结果的分析,包括视敏度和视网膜厚度.
主要成果:
- 红光 (630-800nm) 有效地准线粒体,增强细胞能量生产.
- 临床研究表明,治疗后视觉活动得到改善,视网膜厚度减少.
- 在与年龄相关的黄斑变性,糖尿病黄斑,近视和急性视网膜光损伤方面,PBM显示出有效性.
结论:
- 光生物调制,特别是红光,为各种视网膜疾病提供了一个有前途的治疗策略.
- 机制包括增强线粒体功能和细胞能量生产.
- 未来的研究应该专注于向治疗,组合治疗和长期疗效研究.
相关概念视频
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

